- WorkersCould expand insurance options for small employers, associations and self-employed individuals by enabling association…
- Targeted stakeholdersIncreased transparency from PBMs (detailed, machine-readable reports on drug prices, rebates, fees, and affiliated-phar…
- Permitting processPermitting employer-funded HRAs that reimburse individuals for coverage in the individual market (with nondiscriminatio…
Lower Health Care Premiums for All Americans Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by t…
The bill makes four broad changes: (1) it expands and establishes rules for association health plans (AHPs), allowing groups or associations of employers — including aggregations of self‑employed individuals — to sponsor group health plans across industries subject to governance, nondiscrimination, and eligibility requirements; (2) it clarifies treatment of certain stop‑loss insurance and preemption of state laws for plans that insure against excess claims; (3) it creates a framework treating certain employer-funded health reimbursement arrangements (called “custom health option and individual care expense arrangements” or CHOICE arrangements) as meeting specified ACA market rules and adds W‑2 reporting requirements; (4) it imposes extensive reporting, transparency, privacy rules, and civil penalties around pharmacy benefit managers (PBMs) and related entities, and (5) it authorizes appropriations to fund cost‑sharing reduction (CSR) payments for plans starting 2027 but bars use of those funds for plans that cover abortion except in narrow life/rape/incest cases.
The bill amends ERISA, the Public Health Service Act, and the Internal Revenue Code and directs rulemaking and enforcement authorities to implement many provisions.
On content alone, the bill combines technically detailed regulatory reforms (PBM transparency) that can attract bipartisan support with more overtly partisan market‑expanding and values‑laden provisions (association health plans expansion, CSR funding with abortion carve‑out). Its broad scope and fiscal exposure increase legislative friction; while some components could be folded into larger negotiations or passed as narrower, noncontroversial pieces, the full package as written faces meaningful hurdles to enactment.
How solid the drafting looks.
AHPs and CHOICE HRAs: progressive fears adverse selection and weakened ACA markets; conservatives view these as pro‑choice, pro‑market reforms.
Who stands to gain, and who may push back.
- Permitting processAssociation health plans that cross industries and permit employer-specific contributions based on risk could increase…
- Targeted stakeholdersExtensive new reporting and disclosure requirements for PBMs, issuers and plans will impose administrative and IT compl…
- ConsumersTreating certain stop‑loss policies as not being health insurance and preempting state laws related to insuring excess…
Why the argument around this bill splits.
AHPs and CHOICE HRAs: progressive fears adverse selection and weakened ACA markets; conservatives view these as pro‑choice, pro‑market reforms.
A mainstream progressive view would see some useful elements (PBM transparency, CSR funding) but be highly concerned overall.
The expansion of association health plans and the CHOICE HRA provisions are likely to be read as mechanisms that could steer healthier employees and employers away from the individual marketplace and large community‑rated risk pools, risking adverse selection and higher premiums for sicker or poorer people.
The bill’s preemption language on stop‑loss and the treatment of self‑employed individuals as employer‑members raise concerns about state consumer protections being weakened.
A pragmatic moderate would view the bill as a mix of potentially helpful transparency and choice reforms and meaningful risks that require careful safeguards.
PBM reporting is broadly welcome as a transparency and oversight measure, though the reporting scope and privacy protections will need clear, workable rulemaking to avoid administrative burden.
Expanding AHPs and allowing employer HRAs tied to individual coverage may increase options and lower costs for some employers, but raises legitimate concerns about adverse selection and market stability that the centrist would want monitored.
A mainstream conservative would generally view the bill favorably for expanding market‑based choices and employer flexibility, particularly the AHP expansion and the CHOICE HRA treatment that let small employers and self‑employed people aggregate purchasing power.
Increased PBM transparency is also attractive as a way to expose pricing distortions and potentially lower costs.
However, conservatives may be wary of adding heavy federal reporting requirements and penalties that increase regulatory burden, and many will be skeptical of new ongoing federal appropriations to fund CSR payments (even if the bill restricts CSR funding for plans that cover abortion).
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill combines technically detailed regulatory reforms (PBM transparency) that can attract bipartisan support with more overtly partisan market‑expanding and values‑laden provisions (association health plans expansion, CSR funding with abortion carve‑out). Its broad scope and fiscal exposure increase legislative friction; while some components could be folded into larger negotiations or passed as narrower, noncontroversial pieces, the full package as written faces meaningful hurdles to enactment.
- No CBO or cost estimate is included in the bill text provided; the fiscal magnitude of the open‑ended CSR appropriation and administrative costs for expanded reporting is unknown and could materially affect support.
- Practical compliance burden and privacy implications of the PBM reporting regime are detailed but will require substantial rulemaking; administrative feasibility and industry legal challenges are uncertain.
Recent votes on the bill.
Passed
On Passage
Failed
On Motion to Recommit
Go deeper than the headline read.
AHPs and CHOICE HRAs: progressive fears adverse selection and weakened ACA markets; conservatives view these as pro‑choice, pro‑market refo…
On content alone, the bill combines technically detailed regulatory reforms (PBM transparency) that can attract bipartisan support with mor…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for Lower Health Care Premiums for All Americans Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.